Is pneumococcal vaccine live or inactivated?
These 23 types cause about 9 out of every 10 infections caused by pneumococcus bacteria. The vaccine is inactivated, which means that it does not contain any live pneumococcal bacteria. It cannot cause pneumococcal disease. In the UK, PPV is given to adults aged 65 and over.
The main difference between the two is the amount of bacteria that the vaccine can help protect against. Pneumovax 23 protects against 23 types of pneumococcal bacteria, while Prevnar 13 protects against 13 types of pneumococcal bacteria.
- Older Adults Need Two Pneumococcal Vaccines. CDC recommends 2 pneumococcal vaccines for all adults 65 years or older. You should receive a dose of PCV13 first, followed by a dose of PPSV23, at least 1 year later.
- PPSV23 for Children and Adults. The pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax®) protects against 23 types of pneumococcal bacteria.
- Pediatric/VFC Vaccine Price List
Vaccine Brandname/ Tradename Private Sector Cost/ Dose Pneumococcal 13-valent  (Pediatric) Prevnar 13 TM $180.05 Pneumococcal Polysaccharide (23 Valent) Pneumovax®23 $94.51 Rotavirus, Live, Oral, Pentavalent  RotaTeq® $82.89 $82.89
Pneumovax 23 (Pneumococcal Vaccine Polyvalent) is a vaccine that helps protect against serious infection, such as ear infection, sinus infection, pneumonia, blood infection (bacteremia), and meningitis (infection of the covering of the brain) due to the bacteria Streptococcus pneumoniae.
- I got a pneumonia shot — and then the pain began. Last December during a routine physical exam, I received a vaccination to protect against several strains of pneumonia. It hurt, more so than the usual injection. In the days that followed, the pain in my left shoulder worsened.
- The main difference between the two is the amount of bacteria that the vaccine can help protect against. Pneumovax 23 protects against 23 types of pneumococcal bacteria, while Prevnar 13 protects against 13 types of pneumococcal bacteria.
- Only a single dose of each vaccine is needed. Those who have already been vaccinated with PPSV23 can get PCV13 later, as long as it's been at least a year since the PPSV23 vaccination. When it comes to preventing pneumonia, the bottom line for older individuals is clear: Get vaccinated twice.
PNEUMOVAX®23 (Pneumococcal Vaccine Polyvalent) is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F).
- The committee recommended that seniors get both the Prevnar 13 and the Pneumovax 23 vaccines. As their names imply, Prevnar 13 protects against 13 types of pneumococcal bacteria, and the Pneumovax 23 protects against 23 types of pneumococcal bacteria.
- PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged ≥2 years who are at increased risk for pneumococcal disease. PNEUMOVAX 23 will not prevent disease caused by capsular types of pneumococcus other than those contained in the vaccine.
- The pneumococcal vaccine is thought to be around 50-70% effective at preventing pneumococcal disease. Both the PPV and the PCV are inactivated or "killed" vaccines and don't contain any live organisms. They can't cause the disease against which they protect.
Updated: 2nd November 2019